CLINICAL_TRIALS trial_result · 2026-04-29

Clinical Trial Update: Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer [Phase 3]

Phase 3 trial evaluating cemiplimab with platinum-based chemotherapy in non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Regeneron Pharmaceuticals | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2026-04-29